tiprankstipranks
Advertisement
Advertisement

Neurogene Approves Amendments at Annual Stockholders Meeting

Story Highlights
Neurogene Approves Amendments at Annual Stockholders Meeting

Elevate Your Investing Strategy:

An update from Neurogene ( (NGNE) ) is now available.

On June 12, 2025, Neurogene Inc. held its Annual Meeting of Stockholders, where amendments to the 2023 Equity Incentive Plan and Employee Stock Purchase Plan were approved. These amendments clarify the inclusion of shares issuable on exercise of prefunded warrants and conversion of preferred stock in the calculation of the automatic share reserve increase. The meeting also included the election of two directors, approval of executive compensation, and ratification of Deloitte & Touche LLP as the independent auditor for 2025.

The most recent analyst rating on (NGNE) stock is a Buy with a $45.00 price target. To see the full list of analyst forecasts on Neurogene stock, see the NGNE Stock Forecast page.

Spark’s Take on NGNE Stock

According to Spark, TipRanks’ AI Analyst, NGNE is a Underperform.

Neurogene’s overall score is primarily influenced by its financial performance, which is challenged by zero revenues and significant net losses. While the stock shows some technical strength, the high beta and potential overbought conditions pose risks. The valuation reflects the speculative nature of investing in an early-stage biotech firm.

To see Spark’s full report on NGNE stock, click here.

More about Neurogene

Neurogene Inc. operates in the biotechnology industry, focusing on developing genetic medicines for patients affected by rare neurological diseases.

Average Trading Volume: 276,578

Technical Sentiment Signal: Sell

Current Market Cap: $307.8M

See more insights into NGNE stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1